Antibiotic Treatment for Respiratory Infections

Introduction to Antibiotic Choice

Amoxicillin-clavulanate (Augmentin) is an excellent choice for H. influenzae respiratory infections, particularly for β-lactamase-producing strains, as recommended by the Infectious Diseases Society of America 1, 2, 3
Treatment should provide activity against H. influenzae, S. pneumoniae, and S. aureus, with options including amoxicillin-clavulanate, cefpodoxime, cefprozil, cefuroxime, or a respiratory fluoroquinolone 4

Adults can be treated with 1.2g IV/PO of amoxicillin-clavulanate every 8-12 hours 1
First-line treatment options include Ceftriaxone 2g IV every 12 hours or Cefotaxime 2g IV every 6 hours 2
Alternative treatment options include Moxifloxacin 400mg once daily 2
For hospitalized patients with non-β-lactamase-producing strains, treatment options include Amoxicillin 500mg three times daily (PO) or Ampicillin 500mg four times daily (IV) 3
For hospitalized patients with β-lactamase-producing strains, treatment options include Co-amoxiclav 625mg three times daily (PO) or 1.2g three times daily (IV) 3

For mild-to-moderate community-acquired infections, a treatment duration of 7 days is typically sufficient 5
The standard recommended duration of treatment for Haemophilus influenzae infections is 10 days, as recommended by the Infectious Diseases Society of America 2, 3
The duration of treatment for hospitalized patients is 7-10 days, with 7 days for non-severe, uncomplicated pneumonia and 10 days for severe pneumonia 3

Monitor for resolution of symptoms such as cough, fever, and purulent sputum 6
Consider oral therapy when there is clear evidence of clinical improvement, temperature has been normal for 24 hours, and no contraindication to oral administration exists 3
Outpatient intravenous therapy should be considered in clinically stable patients, as recommended by the Infectious Diseases Society of America 2

Failure to consider antimicrobial resistance patterns, premature discontinuation of therapy, not adjusting therapy based on clinical response, and overlooking the possibility of complications requiring extended treatment are common mistakes to avoid in the treatment of Haemophilus influenzae infections 3
β-lactamase production is common in H. influenzae, and β-lactamase stable antibiotics such as Co-amoxiclav, Cephalosporins (cefuroxime, cefotaxime, ceftriaxone), and Fluoroquinolones should be used for β-lactamase-producing strains 3